Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Hoffmann

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Medical Oncology|May 17, 2021
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practiceWolfgang M Brückl, Martin Reck, Frank Griesinger, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Diagnostic accuracy of plasma kynurenine/tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosisClement Gascua Adu-Gyamfi, Tracy Snyman, Lillian Makhathini, et al.
Trials|August 5, 2022
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contactsSamyra R Cox, Abhay Kadam, Sachin Atre, et al.
Science Translational Medicine|November 17, 2017
A role for bacterial urease in gut dysbiosis and Crohn's diseaseJosephine Ni, Ting-Chin David Shen, Eric Z Chen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Medical Oncology|May 17, 2021
Afatinib as first-line treatment in patients with <i>EGFR</i>-mutated non-small cell lung cancer in routine clinical practiceWolfgang M Brückl, Martin Reck, Frank Griesinger, et al.
Cancer Research|January 8, 2013
Specific elimination of CD133+ tumor cells with targeted oncolytic measles virusPatricia Bach, Tobias Abel, Christopher Hoffmann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Diagnostic accuracy of plasma kynurenine/tryptophan ratio, measured by enzyme-linked immunosorbent assay, for pulmonary tuberculosisClement Gascua Adu-Gyamfi, Tracy Snyman, Lillian Makhathini, et al.
Trials|August 5, 2022
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contactsSamyra R Cox, Abhay Kadam, Sachin Atre, et al.
Science Translational Medicine|November 17, 2017
A role for bacterial urease in gut dysbiosis and Crohn's diseaseJosephine Ni, Ting-Chin David Shen, Eric Z Chen, et al.
Pageof 2